- Saturday, March 15, 2025
- India +91 7982732466
- U.S +1 217 953 4020
- Info@Shingetsuresearch.com
Global Virtual Diagnostics Market by Type of Diagnosis (Gastrointestinal Virtual Diagnostics, Ophthalmology Virtual Diagnostics, Cardiology Virtual Diagnostics Market, Pathology Virtual Diagnostics and Others), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers and Others), and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa)
Global Virtual Diagnostics Market Overview
Global Virtual Diagnostics Market is estimated to reach USD 2318.68 million by 2030, growing at a CAGR of 14.78% during the forecast period of 2022-2030. It was valued at USD 748.94 million in 2022. Virtual Diagnostics provides emergency care and foundations for patients with chronic conditions and other high-risk patients who need frequent examinations of medical consultation. Virtual Diagnostics allows patients to communicate with doctors whenever they need them. Health systems and consumer-facing healthcare providers see point-of-care testing and digital diagnostic services as the next enhancement to the virtual care platform. Through this, patients could see a doctor online for a nagging health issue, and provide labs and tests done from home, holds promise to ease traffic bottlenecks at doctor’s offices, and improve patient engagement and satisfaction with telehealth.Global Virtual Diagnostics Market Insights
The increasing awareness for early disease diagnosis and increasing demand for accessible and affordable diagnostics are vital factors expected to drive the global virtual diagnostics market in the future timeframe. Moreover, the growing number of diabetic patients around the world, coupled with an increasing preference for self-diagnosis and technological advancements in the diagnostic technology, will boost the global virtual diagnostics market in the upcoming periods. Additionally, the rise in geriatric population across the world and the subsequent growth in the prevalence of chronic and infectious diseases worldwide will augment the global virtual diagnostics industry in the expected periods. The development of pathological AI to assist diagnosis will effectively reduce the workload of pathologists. Furthermore, increasing the adoption of fully automated instruments in diagnostic laboratories, which are more scalable, high-performance, help in decreasing hands-on time, and eliminate batch testing will expand the demand for virtual diagnostics in the near future. Digital pathological images can observe the tissue and cell morphology. Further, the rise in demand for virtual diagnostics for reducing by 20X the false positive rate in detection, which projected to accelerate the global virtual diagnostics market size in the estimated periods.Growth Driver
The surge in geriatric population
According to the United Nations, there are 703 million people aged 65 or older, a number that is projected to reach 1.5 billion by 2050. According to the latest population estimates and projections from UN DESA’s Population Division, 1 in 6 people in the world will be over the age of 65 by 2050, up from 1 in 11 in 2019. The latest projections also show that the number of people aged 80 or over will triple in the next 30 years.Huge application AI based Diagnostics System
Patients come to the emergency department, and nurses can get their vital signs, basic medical history, and physical examination data into the model. AI is allowing algorithms to generate predictive diagnoses to help physicians select which patients to prioritize. AI helps physicians decide which patients to prioritize and help physicians diagnose complex or rare diseases. AI diagnosis technology can greatly reduce the workload of doctors and image data processing, and interpretation of results that need to be overcome.Type of Diagnosis Segmental Analysis
Based on the type of diagnosis, the global Virtual Diagnostics market classified into Gastrointestinal Virtual Diagnostics, Ophthalmology Virtual Diagnostics, Cardiology Virtual Diagnostics, Pathology Virtual Diagnostics, and Others. The Cardiology Virtual Diagnostics segment projected to dominate the market by 2030, owing to the growing demand for the Virtual Diagnostics for remote monitoring to detect rhythm disturbances and blood glucose levels. It helps patient electronic medical records containing laboratory test results, physician’s notes, and other information on the disease, treatment, and epidemiology. Pathology Virtual Diagnostics will be the fastest-growing segment by 2030, as it provides real-time guidance on risk, clinical care options, and outcomes. It also helps in blood test analysis.End-User Segmental Analysis
Based on end-user, the global Virtual Diagnostics market categorized into Hospitals, Clinics, Ambulatory Surgical Centers, and Others. Hospitals segment expected to gain maximum revenue by 2030 on account of the large volume of diagnostic tests carried out in hospitals coupled with rising demand for rapid tests among patients. Clinics segment will boom by the application of virtual diagnostics, which are capable of identifying all patients’ problems with the help of AI and machine learning.Region Segmental Analysis
Based on geography, the global Virtual Diagnostics market size segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America estimated to occupy the lion’s market share by 2030, owing to the high adoption of new technology in healthcare systems in the region coupled with the local presence of major players in the virtual diagnostics industry. The Asia Pacific will drive by the increasing incidence of chronic diseases, rising healthcare spending by developing countries, and healthcare by the government’s reforms for infrastructural development.Competitor Analysis
Companies such as AliveCor Inc., Cardiologs Technologies, CapsoVision, Inc, Eyenuk, Inc, Healthy.io Ltd., hearX IP (Pty) Ltd, Hill-Rom Holdings, Inc., IDx Technologies Inc., Medtronic Plc., Monitored Therapeutics Inc., Olympus Corporation, Phelcom Technologies, and ResApp Health Limited are the key players in the Global Virtual Diagnostics Market.Key Stakeholders
- Market research and consulting firms
- Industry associations
- Global Virtual Diagnostics service providers
- Research organizations and consulting companies
- Organizations, associations, and alliances related to Virtual Diagnostics
- Regulatory bodies
Scope of the result
| Report Attribute | Details |
|---|---|
| Market size value in 2020 | USD 525 million |
| Revenue forecast in 2027 | USD 1120 million |
| Growth Rate | CAGR of 14.78% from 2020 to 2027 |
| Historical data | 2017-2019 |
| Forecast period | 2021 – 2027 |
| Region covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
| Key companies Profiled | AliveCor Inc., Eyenuk, Inc, Healthy.io Ltd., Cardiologs Technologies, CapsoVision, Inc, hearX IP (Pty) Ltd, ResApp Health Limited, Olympus Corporation, Phelcom Technologies, Hill-Rom Holdings, Inc., IDx Technologies Inc., Medtronic Plc., and Monitored Therapeutics Inc. |
Recent Developments
- In September 2021, the U.S. FDA approved Tissue-Based NGS Companion Diagnostic for Takeda’s Targeted Therapy for NSCLC patients with EGFR Exon20 insertion mutations.
- In November 2020, VitalConnect announced the launch of VitalPatch® RTM for patients who require extended Holter monitoring.
- In April 2020, Cardiologs announced a clinical study to monitor cardiac safety of COVID-19 patients via smartwatches.
The objective of the Research
- Market modeling starts with identifying a target market where historical data exists. A Market can include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our client to have deep dive into the market.
- Product analysis involves steps such as examining product features, costs, availability, quality, and other aspects. Product analysis is conducted to understand potential buyers and measure competition in the market.
- Market Trend and Economic Factors Analysis helps in assessing potential changes to an economy’s inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can or have a major effect on the target market.
- Market Segmental Analysis defines in-depth scenario of the target market by the process of grouping consumers into naturally existing created segments of consumers who share similar product preferences or characteristics
- The geographical mapping approach helps our clients to understand national or international markets because different consumers in different regions have different needs wants, and cultural characteristics that can be specifically targeted.
Market Modelling
By Type of Diagnosis- Gastrointestinal Virtual Diagnostics
- Ophthalmology Virtual Diagnostics
- Cardiology Virtual Diagnostics
- Pathology Virtual Diagnostics
- Others
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
More Related Reports:
Respiratory Care Device Market
In Silico Drug Discovery Market
Report Content
- Research Strategic Development
1.1. Market Modelling
1.2. Product Analysis
1.3. Market Trend and Economic Factors Analysis
1.4. Market Segmental Analysis
1.5. Geographical Mapping
1.6. Country Wise Segregation
- Research Methodology
2.1. Identification of Target Market
2.2. Data Acquisition
2.3. Refining of Data/ Data Transformations
2.4. Data Validation through Primary Techniques
2.5. Exploratory Data Analysis
2.6. Graphical Techniques/Analysis
2.7. Quantitative Techniques/Analysis
2.8. Visual Result/Presentation
- Executive Summary
- Market Insights
4.1. Supply Chain Analysis
4.2. Economic Factor Analysis
4.2.1. Drivers
4.2.2. Trends
4.2.3. Opportunities
4.2.4. Challenges
4.3. Technological Landscape
4.4. Competitors & Product Analysis
4.5. Regulatory Framework
4.6. Company market share analysis, 2022
4.7. Porter’s Five forces analysis
4.8. Price point analysis
4.9. New Investment Analysis
4.10. PESTEL Analysis
- Global Virtual Diagnostics Market Overview
5.1. Market Size & Forecast,2017-2030
5.1.1. Demand
5.1.1.1. By Value (USD Million)
5.2. Market Share & Forecast, 2017-2030
5.2.1. By Types of Diagnosis
5.2.1.1. Gastrointestinal Virtual Diagnostics
5.2.1.2. Ophthalmology Virtual Diagnostics
5.2.1.3. Cardiology Virtual Diagnostics
5.2.1.4. Pathology Virtual Diagnostics
5.2.1.5. Others
5.2.2. By End-User
5.2.2.1. Hospitals
5.2.2.2. Clinics
5.2.2.3. Ambulatory Surgical Centers
5.2.2.4. Others
5.2.3. By Region
5.2.3.1. North America
5.2.3.2. Europe
5.2.3.3. Asia-Pacific
5.2.3.4. South America
5.2.3.5. The Middle East & Africa
- North America Virtual Diagnostics Market Overview
6.1. North America Virtual Diagnostics Market Size & Forecast,2017-2030
6.1.1. Demand
6.1.1.1. By Value (USD Million)
6.2. Market Share & Forecast, 2017-2030
6.2.1. By Types of Diagnosis
6.2.1.1. Gastrointestinal Virtual Diagnostics
6.2.1.2. Ophthalmology Virtual Diagnostics
6.2.1.3. Cardiology Virtual Diagnostics
6.2.1.4. Pathology Virtual Diagnostics
6.2.1.5. Others
6.2.2. By End-User
6.2.2.1. Hospitals
6.2.2.2. Clinics
6.2.2.3. Ambulatory Surgical Centers
6.2.2.4. Others
6.2.3. By End-User
6.2.3.1. Hospitals
6.2.3.2. Clinics
6.2.3.3. Pharmacy Store
6.2.3.4. Others
6.2.4. By Country
6.2.4.1. US
6.2.4.2. Canada
6.2.4.3. Mexico
6.2.5. Company Market Share (Top 3-5)
6.2.6. Economic Impact Study on North America Virtual Diagnostics Market
- Europe Virtual Diagnostics Market Overview
7.1. Europe Virtual Diagnostics Market Size & Forecast,2017-2030
7.1.1. Demand
7.1.1.1. By Value (USD Million)
7.2. Market Share & Forecast, 2017-2030
7.2.1. By Types of Diagnosis
7.2.1.1. Gastrointestinal Virtual Diagnostics
7.2.1.2. Ophthalmology Virtual Diagnostics
7.2.1.3. Cardiology Virtual Diagnostics
7.2.1.4. Pathology Virtual Diagnostics
7.2.1.5. Others
7.2.2. By End-User
7.2.2.1. Hospitals
7.2.2.2. Clinics
7.2.2.3. Ambulatory Surgical Centers
7.2.2.4. Others
7.2.3. By End-User
7.2.3.1. Hospitals
7.2.3.2. Clinics
7.2.3.3. Pharmacy Store
7.2.3.4. Others
7.2.4. By Country
7.2.4.1. Germany
7.2.4.2. UK
7.2.4.3. France
7.2.4.4. Italy
7.2.4.5. Rest of Europe
7.2.5. Company Market Share (Top 3-5)
7.2.6. Economic Impact Study on Europe Virtual Diagnostics Market
- Asia-Pacific Virtual Diagnostics Market Overview
8.1. Asia-Pacific Virtual Diagnostics Market Size & Forecast,2017-2030
8.1.1. Demand
8.1.1.1. By Value (USD Million)
8.2. Market Share & Forecast, 2017-2030
8.2.1. By Types of Diagnosis
8.2.1.1. Gastrointestinal Virtual Diagnostics
8.2.1.2. Ophthalmology Virtual Diagnostics
8.2.1.3. Cardiology Virtual Diagnostics
8.2.1.4. Pathology Virtual Diagnostics
8.2.1.5. Others
8.2.2. By End-User
8.2.2.1. Hospitals
8.2.2.2. Clinics
8.2.2.3. Ambulatory Surgical Centers
8.2.2.4. Others
8.2.3. By Country
8.2.3.1. India
8.2.3.2. Japan
8.2.3.3. Australia
8.2.3.4. Rest of Asia Pacific
8.2.4. Company Market Share (Top 3-5)
8.2.5. Economic Impact Study on Asia Pacific Virtual Diagnostics Market
- South America Virtual Diagnostics Market Overview
9.1. South America Virtual Diagnostics Market Size & Forecast,2017-2030
9.1.1. Demand
9.1.1.1. By Value (USD Million)
9.2. Market Share & Forecast, 2017-2030
9.2.1. By Types of Diagnosis
9.2.1.1. Gastrointestinal Virtual Diagnostics
9.2.1.2. Ophthalmology Virtual Diagnostics
9.2.1.3. Cardiology Virtual Diagnostics
9.2.1.4. Pathology Virtual Diagnostics
9.2.1.5. Others
9.2.2. By End-User
9.2.2.1. Hospitals
9.2.2.2. Clinics
9.2.2.3. Ambulatory Surgical Centers
9.2.2.4. Others
9.2.3. By Country
9.2.3.1. Brazil
9.2.3.2. Argentina
9.2.3.3. Rest of South America
9.2.4. Company Market Share (Top 3-5)
9.2.5. Economic Impact Study on South America Virtual Diagnostics Market
- The Middle East & Africa Virtual Diagnostics Market Overview
10.1. The Middle East & Africa Virtual Diagnostics Market Size & Forecast,2017-2030
10.1.1. Demand
10.1.1.1. By Value (USD Million)
10.2. Market Share & Forecast, 2017-2030
10.2.1. By Types of Diagnosis
10.2.1.1. Gastrointestinal Virtual Diagnostics
10.2.1.2. Ophthalmology Virtual Diagnostics
10.2.1.3. Cardiology Virtual Diagnostics
10.2.1.4. Pathology Virtual Diagnostics
10.2.1.5. Others
10.2.2. By End-User
10.2.2.1. Hospitals
10.2.2.2. Clinics
10.2.2.3. Ambulatory Surgical Centers
10.2.2.4. Others
10.2.3. By Country
10.2.3.1. Saudi Arabia
10.2.3.2. UAE
10.2.3.3. South Africa
10.2.3.4. Rest of the Middle East & Africa
10.2.4. Company Market Share (Top 3-5)
10.2.5. Economic Impact Study on Middle East & Africa Virtual Diagnostics Market
- Competitor Analysis
11.1. Company Description
11.2. Financial Analysis
11.3. Key Products
11.4. Key Management Personnel
11.5. Contact Address
11.6. SWOT Analysis
11.7. Company Profile
11.7.1. AliveCor Inc.
11.7.2. Cardiologs Technologies
11.7.3. CapsoVision, Inc
11.7.4. Eyenuk, Inc
11.7.5. io Ltd.
11.7.6. hearX IP (Pty) Ltd
11.7.7. Hill-Rom Holdings, Inc.
11.7.8. IDx Technologies Inc.
11.7.9. Medtronic Plc.
11.7.10. Monitored Therapeutics Inc.
11.7.11. Olympus Corporation
11.7.12. Phelcom Technologies
11.7.13. ResApp Health Limited
11.7.14. Other Prominent Players
Frequently Asked Questions (FAQ):
The growth rate of the Global Virtual Diagnostics Market is 14.78% from 2022 to 2030.
Global Virtual Diagnostics Market is estimated to reach USD 2318.68 million by 2030, and It was valued at USD 748.94 million in 2022.
An increase in the geriatric population and increasing demand for accessible and affordable diagnostics are the growth drivers of the Global Virtual Diagnostics Market.
Hospitals, Clinics, Ambulatory Surgical Centers are the end-users of the Virtual Diagnostics Market products.
AliveCor Inc., Eyenuk, Inc, Healthy.io Ltd., Cardiologs Technologies, CapsoVision, Inc, hearX IP (Pty) Ltd, ResApp Health Limited, Olympus Corporation, Phelcom Technologies, Hill-Rom Holdings, Inc., IDx Technologies Inc., Medtronic Plc., and Monitored Therapeutics Inc. are the key players in the Global Virtual Diagnostics Market.
